Brief: Sight Sciences announces long-term safety and effectiveness data of standalone use of the Omni® surgical system in patients with open angle glaucoma
16/08/2022 13:20
Aug 16 (Reuters) - Sight Sciences Inc SGHT.O :
* SIGHT SCIENCES ANNOUNCES LONG-TERM SAFETY AND
EFFECTIVENESS DATA
OF STANDALONE USE OF THE OMNI® SURGICAL SYSTEM IN PATIENTS WITH
OPEN ANGLE GLAUCOMA
* SIGHT SCIENCES-DATA SHOWS OMNI SURGICAL SYSTEM DELIVERS
SAFE,CONSISTENT,DURABLE RESULTS IN ADULT PATIENTS WITH
OPEN-ANGLE GLAUCOMA ON STANDALONE BASIS
Source text for Eikon: ID:nGNX23jfV9
Further company coverage: SGHT.O
Recent news on Sight Sciences
See all newsSight Sciences raises FY 2026 revenue outlook
Brief: Sight Sciences Q1 Revenue USD 19.7 Million Vs. IBES Estimate USD 18.5 Million
Brief: Sight Sciences U.S. District Court Issued Order On Post-Trial Motions In Patent Infringement Case Against Alcon Originally Filed On Sep 16, 2021
Sight Sciences Q4 revenue rises 7%
Brief: Sight Sciences Announces Preliminary, Unaudited Fourth Quarter And Full Year 2025 Financial Highlights